Delivery Order SPE2DB24D1205-SPE2DB25FCWSD
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,917.07, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,974.59, is for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $25,549.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication BIMZELX 160 MG/ML AUTOINJECTORML, with a performance period ending on May 2, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $9,407.04 and an Ultimate Completion Date of April 9, 2025. The contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIMZELX 320 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $23,436.63 and a period of performance through May 6, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,292.36 Firm Fixed Price Delivery Order (SPE2DB22D2211) is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR, a specialty medication, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMKSN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,405.92 Firm Fixed Price delivery order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with the ID SPE2DX15D3005|SPE2DX24F3SPG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,187.00, is a Firm Fixed Price Delivery Order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has a period of performance through July 5, 2024. Amerisourcebergen Drug Corp is the prime contractor...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $747,639.24, is for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $757,004.44, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999.00, which...